Belluscura plc (BELL.L) Research

Belluscura plc, established in London, United Kingdom in 2015, specializes in the creation and market introduction of medical devices designed for oxygen therapy. Among their key offerings is the X-PLO2R, an innovative modular and portable oxygen concentrator.

Market snapshot

Symbol
BELL.L
Price
$0.75
Day change
+3.45%
Market cap
$4.0M
P/E ratio
-0.07x
52-week range
0.495-18
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Cel AI PLC (CLAI.L)
  • Deltex Medical Group plc (DEMG.L)
  • Destiny Pharma plc (DEST.L)
  • DeepVerge plc (DVRG.L)
  • IQ-AI Limited (IQAI.L)
  • Kanabo Group Plc (KNB.L)
  • Oxford Cannabinoid Technologies Holdings Plc (OCTP.L)
  • ReNeuron Group plc (RENE.L)

Open Belluscura plc (BELL.L) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.